Nurturing Early Life Gut Health with B. infantis M-63

Discover the science and benefits of Bifidobacterium infantis M-63 for optimal infant gut health and beyond. Join our expert-led session!

26

March

  • 3PM London / 10AM New York
  • Free
  • Why attend?
  • Speakers
  • Contact Us

Why attend?

In today’s health landscape, the importance of gut health cannot be overstated, especially for infants. Research has highlighted the differences in gut bacteria composition between breast-fed and formula-fed infants, emphasising the need for solutions that effectively nurture infant gut microbiota. Nevertheless, as more women enter the workforce, breastfeeding may not be feasible, so the challenge lies in developing alternatives that match the benefits of natural breastfeeding.

Join us for this insightful webinar where we will explore this developing landscape in more detail, taking a closer look at the bifidobacterium longum subsp. infantis M-63, which has been identified as a promising probiotic. With its unique ability to utilise human milk oligosaccharides (HMOs) – an essential component of human breast milk – M-63 presents significant potential for supporting the healthy development of the infant gut microbiota. This, combined with rising concerns over gut-related issues in infants, indicates an urgent need to research scientifically validated probiotics like M-63.

With expert input and analysis from GlobalData’s Fiona Dyer, Principal Analyst – Consumer Food and Drink, and Morinaga Milk, a leading provider of a dairy company and leader in probiotics research, attendees will gain a better understanding of:

  • The global trends and themes in the infant-food market in 2025
  • The higher colonisation potential and safety of M-63 and its impact on infant gut health, including regulatory approvals and quality assurances
  • Its practical applications in infant food products

Join us for this engaging and informative session that promises to equip you with valuable insights and practical tips on M-63. Register now to secure your spot and stay ahead in the field of infant gut health.

Speakers

Select a speaker to learn more

Back
Saki Yamashita
Marketing Strategy Manager, International BtoB Business Dept

Joining the company in 2012, Saki has gained extensive experience in Logistics, Administration, and International Business Operations. Since 2018, she has been actively involved in the probiotics/postbiotic field. She successfully promoted probiotics and postbiotics business in the EMEA region when she was appointed as a Commercial Manager in Germany for nearly 4 years. Currently, she is based in the headquarters in Tokyo and is passionate about utilizing her previous learnings and skills to further support Morinaga Milk's Probiotics/Postbiotic global business expansion through marketing activities.​ 

Next speaker
Back
Fiona Dyer
Principal Analyst

Fiona is a Principal Analyst at GlobalData. She has over 30 years experience in the FMCG sector, writing and editing reports as well as several trade publications. Her particular areas of expertise lie in tobacco and baby food. Fiona’s views on the consumer food, drink and tobacco industry over the years have been quoted in several industry publications both print and online, with articles published in a wide variety of trade publications  from Forbes, to The Lady via Drinks International. Fiona has presented at a several conferences including a ground breaking gathering of leading FMCG giants in Budapest newly emerging from a communist based political regime.  Fiona has also presented  at board level.

Next speaker

Enquiry